cGVHD-associated graft-versus-tumor effects (GVT)
Showing 1 - 25 of >10,000
Clinical and Biological Factors Determining Outcomes in Chronic
Recruiting
- Chronic Graft vs Host Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Immunoregulatory T Lymphocytes Subtypes and Haematopoietic Stem
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies
- Recipients
- Donors
-
Paris, FranceHopital Necker
Nov 19, 2021
Patients at Risk for Chronic Graft-Versus-Host Disease
Not yet recruiting
- cGVHD
- Non-Interventional
- (no location specified)
Jun 16, 2023
Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- +2 more
- Biopsy
- +11 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 7, 2023
Chronic Graft-versus-host-disease Trial in United States (SNDX-6352)
Active, not recruiting
- Chronic Graft-versus-host-disease
-
Birmingham, Alabama
- +10 more
Aug 18, 2022
Microbiota Composition With cGVHD After Allo-HSCT
Recruiting
- Hematopoietic Stem Cell Transplantation
- +3 more
- blood sample
- stool sample
-
Hangzhou, Zhejiang, China
- +9 more
Jul 31, 2022
Chronic Graft-versus-host-disease Trial in United States (Belumosudil (KD025))
Recruiting
- Chronic Graft-versus-host-disease
- Belumosudil (KD025)
-
Birmingham, Alabama
- +35 more
Sep 18, 2022
Chronic GVHD Trial in Atlanta (Belumosudil, Rituximab)
Not yet recruiting
- Chronic Graft Versus Host Disease
-
Atlanta, GeorgiaNorthside Hospital
Sep 21, 2023
Chronic GVHD Trial in United States (drug, procedure, other)
Not yet recruiting
- Chronic Graft Versus Host Disease
- Belumosudil
- +3 more
-
Tampa, Florida
- +4 more
Aug 10, 2023
Dry Eye Trial in Guangzhou (Umbilical Mesenchymal Stem Cells derived Exosomes)
Recruiting
- Dry Eye
- Umbilical Mesenchymal Stem Cells derived Exosomes
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Feb 10, 2022
Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)
Recruiting
- Chronic Graft Versus Host Disease
- Steroid Refractory Graft Versus Host Disease
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Chronic GVHD Trial in Boston (Abatacept)
Active, not recruiting
- Chronic Graft Versus Host Disease
-
Boston, Massachusetts
- +1 more
Jan 25, 2022
Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute
Recruiting
- Chronic Graft vs Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Ibrutinib in Steroid Dependent/Refractory cGVHD Participants
Recruiting
- Chronic Graft vs Host Disease
-
Bucheon-Si, Korea, Republic of
- +9 more
Jan 27, 2023
Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))
Recruiting
- Mesenchymal Stem Cells
- Mesenchymal Stem Cells (MSCs)
-
Shapingba, Chongqing, ChinaXinqiao Hospital
Nov 24, 2023
Chronic GVHD Trial in Worldwide (Ibrutinib)
Active, not recruiting
- Chronic Graft Versus Host Disease
-
Duarte, California
- +47 more
Jul 15, 2022
A Prospective Observational Study for Evaluating CGVHD
Completed
- Chronic Graft-Versus-Host Disease
-
Alessandria, Italy
- +26 more
Nov 23, 2022
Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation, Leukemia Trial
Not yet recruiting
- Chronic Graft-versus-Host-Disease
- +4 more
- (no location specified)
Jan 11, 2023
Neuroblastoma Trial in Guangzhou (Anti Thymocyte Globulin, Fludarabine, Cyclophosphamide injection)
Not yet recruiting
- Neuroblastoma
- Anti Thymocyte Globulin
- +10 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jun 29, 2022
Chronic Graft-versus-host Disease Trial in Worldwide (Itacitinib, Placebo, Methylprednisolone)
Active, not recruiting
- Chronic Graft-versus-host Disease
- Itacitinib
- +3 more
-
Tucson, Arizona
- +132 more
Oct 17, 2022
Chronic GVHD Trial in Duarte (biological, procedure, other)
Active, not recruiting
- Chronic Graft Versus Host Disease
- Aldesleukin
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023